PT Maja Agung Latexindo Tbk (IDX:SURI)
Indonesia · Delayed Price · Currency is IDR 79.00
-1.00 (-1.27%)
Feb 10, 2026, 9:30 AM WIB
IDX:SURI Revenue
PT Maja Agung Latexindo Tbk had revenue of 42.77B IDR in the quarter ending September 30, 2025, with 14.63% growth. This brings the company's revenue in the last twelve months to 153.97B, up 42.52% year-over-year. In the year 2024, PT Maja Agung Latexindo Tbk had annual revenue of 116.67B with 42.77% growth.
Revenue (ttm)
153.97B
Revenue Growth
+42.52%
P/S Ratio
3.25
Revenue / Employee
1.08B
Employees
143
Market Cap
500.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 116.67B | 34.95B | 42.77% |
| Dec 31, 2023 | 81.72B | -11.61B | -12.44% |
| Dec 31, 2022 | 93.33B | -244.80B | -72.40% |
| Dec 31, 2021 | 338.13B | 24.75B | 7.90% |
| Dec 31, 2020 | 313.37B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 34.38T |
| PT Siloam International Hospitals Tbk | 12.51T |
| PT Soho Global Health Tbk | 10.51T |
| PT Sejahteraraya Anugrahjaya Tbk | 3.30T |
| PT Itama Ranoraya Tbk | 1.41T |
| PT Kedoya Adyaraya Tbk | 448.65B |
| PT Ikapharmindo Putramas Tbk | 379.27B |
| PT Indofarma Tbk | 206.24B |